Kartikeya is an experienced healthcare and pharma executive with over 10 years of experience. He has led diverse teams across five countries in roles spanning from driving complex post-merger integrations to building biotech pipelines from scratch. Drove value creation programs like M&A, operating model design, go-to-market strategy, and OpEx leading to a $3 billion cumulative value generated. He is excited to freelance to help organizations build transformative products for society
Head of Portfolio Strategy and Operations | Precision Medicine
2021 - PRESENT
Established an organizational blueprint from scratch and set up eight workstreams to deliver a strategic roadmap of the new organization with 130 FTEs and a $120 million budget.
Led portfolio management of the diagnostics and biomarker portfolio, driving value creation initiatives across 50 molecules with a cumulative expected NPV of $70 billion.
Delivered a 5-year roadmap to the CEO of a San Diego-based diagnostic subsidiary with 180 FTEs and an $80 million budget. Identified technologies, capabilities, and investments to drive future growth strategy.
Drove over 10 business development projects of $300 million deal value by managing deal sourcing, due diligence, and term sheet finalization.
Associate Director of Portfolio Strategy and Management
2020 - 2021
Led initiatives to increase recruitment of underrepresented minorities in clinical trials. Obtained a $20 million commitment to scholarships for black students in healthcare fields and a $14 million investment for a research center at Morehouse University.
Established a post-acquisition integration roadmap for gene therapy player acquired for $8.7 billion. Identified synergies that were cumulating to $120 million in savings.
Led the Pipeline of the future program. An enterprise initiative to build the R&D pipeline of the future.
Established a strategy and an operating model for an R&D center of excellence for digital health products, managing 30 FTEs and a $40 million budget.
Focus areas: Operational Excellence, Program Management, Digital Health, Change Management, Biotechnology, Medical Devices, ESG, Post-Merger Integration, Post-merger Integration, Portfolio Management
Strategy Lead | Operations
2019 - 2020
Delivered savings of $1.1 million through an initiative driving the automation and off-shoring of non-core activities across seven manufacturing sites in Austria, Germany, Belgium, Ireland, and Switzerland.
Led the rollout of an analytics tool mapping inventory data, $3 billion+value across 60 production sites and 120 countries.
Created the blueprint and organized a worldwide hackathon to co-create the 3-year quality transformation plan.
Established the Quality Venture Fund, an in-house incubator that injects $1 million per year into high potential ideas across the network.
Nominated by Novartis Quality community for the Quality 2018 Award to win two out of the seven awards given at the year-end Townhall to associates for exceptional performance.
Acted as the program manager for task forces and tiger teams deployed to solve critical issues across the network. Led cross-functional teams spanning manufacturing, commercial, legal, communications, R&D, and supply chains.
Scaled the Nitrosamine task force, a task force responding to carcinogenic impurities detected in key products from 5 to 90 FTEs within a year while managing a budget of $19 million.
Led the batch release workstream of a critical tiger team by implementing actions to improve the batch release throughput time by 30% enabling inventory savings of $24 million.
Focus areas: Business Transformation, Turnaround, Crisis Management, Strategy, Production & Quality, Change Management
Sandoz Talent Excellence Program
2015 - 2017
Accelerated rotational program with 9-month assignments in R&D, quality, and manufacturing at different locations worldwide. I was one of the 10 applicants chosen out of around 1,000.
Deep-dived past product write-off data and presented an improvement plan to site management.
Led the creation and endorsement of the 2017 quality strategic plan. Consolidated a plan to drive initiatives across 60 manufacturing sites and 120 countries.